StonvexLoading…
StonvexStonvexStonvexCore line items from NEO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $727.33M | $660.57M | $591.64M | $509.73M |
Operating Income | $-115.88M | $-92.11M | $-107.74M | $-157.62M |
Net Income | $-108.03M | $-78.73M | $-87.97M | $-144.25M |
EPS (Diluted) | $-0.84 | $-0.62 | $-0.70 | $-1.16 |
Total Assets | $1.36B | $1.64B | $1.68B | $1.74B |
Total Liabilities | $523.27M | $735.70M | $739.69M | $742.01M |
Cash & Equivalents | $159.62M | $367.01M | $342.49M | $263.18M |
Free Cash Flow OCF − CapEx | $-21.78M | $-34.04M | $-30.70M | $-96.88M |
Shares Outstanding | 128.15M | 128.15M | 127.37M | 126.91M |